These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9205939)

  • 1. The effects of atenolol and zofenopril on plasma atrial natriuretic peptide are due to their interactions with target organ damage of essential hypertensive patients.
    Elijovich F; Laffer CL; Schiffrin EL
    J Hum Hypertens; 1997 May; 11(5):313-9. PubMed ID: 9205939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive efficacy of zofenopril compared with atenolol in patients with mild to moderate hypertension.
    Nilsson P
    Blood Press Suppl; 2007 Oct; 2():25-30. PubMed ID: 18046976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating atrial natriuretic polypeptide in essential hypertension.
    Kohno M; Yasunari K; Matsuura T; Murakawa K; Takeda T
    Am Heart J; 1987 May; 113(5):1160-3. PubMed ID: 2953220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opposite effects of losartan and atenolol on natriuretic peptides in patients with hypertension and left ventricular hypertrophy: a LIFE substudy.
    Olsen MH; Wachtell K; Tuxen C; Fossum E; Bang LE; Hall C; Ibsen H; Rokkedal J; Devereux RB; Hildebrandt PR
    J Hypertens; 2005 May; 23(5):1083-90. PubMed ID: 15834296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of losartan and atenolol on left ventricular mass and neurohormonal profile in patients with essential hypertension and left ventricular hypertrophy.
    Dahlof B; Zanchetti A; Diez J; Nicholls MG; Yu CM; Barrios V; Aurup P; Smith RD; Johansson M;
    J Hypertens; 2002 Sep; 20(9):1855-64. PubMed ID: 12195129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension.
    Nishikimi T; Yoshihara F; Morimoto A; Ishikawa K; Ishimitsu T; Saito Y; Kangawa K; Matsuo H; Omae T; Matsuoka H
    Hypertension; 1996 Jul; 28(1):22-30. PubMed ID: 8675258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Zofenopril vs. Irbesartan in Combination with a Thiazide Diuretic in Hypertensive Patients with Multiple Risk Factors not Controlled by a Previous Monotherapy: A Review of the Double-Blind, Randomized "Z" Studies.
    Omboni S; Malacco E; Napoli C; Modesti PA; Manolis A; Parati G; Agabiti-Rosei E; Borghi C
    Adv Ther; 2017 Apr; 34(4):784-798. PubMed ID: 28260186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of sulfhydryl and non-sulfhydryl angiotensin-converting enzyme inhibitors on endothelial function in essential hypertensive patients.
    Pasini AF; Garbin U; Nava MC; Stranieri C; Pellegrini M; Boccioletti V; Luchetta ML; Fabrizzi P; Lo Cascio V; Cominacini L
    Am J Hypertens; 2007 Apr; 20(4):443-50. PubMed ID: 17386354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurohormonal activity and left ventricular geometry in patients with essential arterial hypertension.
    Muscholl MW; Schunkert H; Muders F; Elsner D; Kuch B; Hense HW; Riegger GA
    Am Heart J; 1998 Jan; 135(1):58-66. PubMed ID: 9453522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of beta-adrenergic receptor blockade on atrial natriuretic peptide in essential hypertension.
    Nakaoka H; Kitahara Y; Amano M; Imataka K; Fujii J; Ishibashi M; Yamaji T
    Hypertension; 1987 Aug; 10(2):221-5. PubMed ID: 3038746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial natriuretic peptide in human essential hypertension.
    Zachariah PK; Burnett JC; Ritter SG; Strong CG
    Mayo Clin Proc; 1987 Sep; 62(9):782-6. PubMed ID: 2957551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial natriuretic peptide and brain natriuretic peptide release in human essential hypertension.
    Soualmia H; Ayadi I; Omar S; Feki M; Drissa H; Mebazaa A; Kaabachi N
    Clin Lab; 2009; 55(3-4):120-7. PubMed ID: 19462934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence and distribution of atrial natriuretic peptide-containing cells in the left ventricle of hypertensive rats. Effect of antihypertensive treatment.
    Kaganovsky E; Belkin V; Barhum Y; Schaper J; Schaper W; Kessler-Icekson G
    Cell Tissue Res; 2001 Jan; 303(1):57-67. PubMed ID: 11236005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated plasma atrial natriuretic peptide concentrations in hypertensive patients with acute myocardial infarction.
    Górecki A; Januszewicz A; Opolski G; Lapiński M; Wocial B; Ignatowska-Switalska H; Słomka K; Kochanowski J; Stolarz P
    J Cardiovasc Risk; 1995 Feb; 2(1):45-50. PubMed ID: 7606640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term effects of atenolol and nifedipine on atrial natriuretic peptide, plasma renin activity, and plasma aldosterone in patients with essential hypertension.
    Colantonio D; Casale R; Desiati P; Giandomenico G; Bucci V; Pasqualetti P
    J Clin Pharmacol; 1991 Mar; 31(3):238-42. PubMed ID: 1826912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between plasma atrial natriuretic peptide and left atrial and left ventricular involvement in essential hypertension.
    Wambach G; Bönner G; Stimpel M; Kaufmann W
    J Hypertens; 1988 Jul; 6(7):573-7. PubMed ID: 2971714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure].
    Kobusiak-Prokopowicz M; Swidnicka-Szuszkowska B; Mysiak A
    Pol Arch Med Wewn; 2001 Jun; 105(6):475-82. PubMed ID: 11865578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial and brain natriuretic peptide and endothelin-1 concentration in patients with idiopathic arterial hypertension: the dependence on the selected morphological parameters.
    Irzmański R; Banach M; Piechota M; Kowalski J; Barylski M; Cierniewski C; Pawlicki L
    Clin Exp Hypertens; 2007 Apr; 29(3):149-64. PubMed ID: 17497342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial natriuretic peptide and antihypertensive action due to beta-blockade in essential hypertensive patients.
    Hama J; Nagata S; Takenaka T; Kino H; Kamoi K; Shimada S; Horiuchi M; Katori R
    Angiology; 1995 Jun; 46(6):511-6. PubMed ID: 7785793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in plasma cardiac natriuretic peptides concentrations during 1 year treatment with angiotensin-converting enzyme inhibitor in elderly hypertensive patients with left ventricular hypertrophy.
    Kohno M; Yokokawa K; Yasunari K; Kano H; Minami M; Hanehira T; Yoshikawa J
    Int J Clin Pharmacol Ther; 1997 Jan; 35(1):38-42. PubMed ID: 9021441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.